Contract Manufacturing

PCI Pharma Services announced that it made a series of infrastructure investments to deepen its sterile fill-finish and advanced drug delivery capabilities. Philadelphia-based PCI says its latest investments come as part of a broader commitment exceeding $1 billion. Its investment spans across its U.S. and European operations. The company hopes to provide seamless support for…

Freudenberg Medical has launched a new ISO Class 5 controlled cleanroom at its Kaiserslautern, Germany site to deliver washed, dried and gamma-sterilized single-use assemblies to biopharmaceutical customers, the company announced ahead of INTERPHEX 2026 in New York (April 21-23). The service, branded CleanAssure, is pitched at biomanufacturers looking to push more of the cleaning and…

Kincell Bio announced that it made a significant strategic investment in the expansion of its Research Triangle Park, North Carolina, facility. The contract development and manufacturing organization (CDMO) supports autologous and allogenic cell therapy programs. It expects the new expansion to support clients as they advance from late-stage clinical CMC development through commercialization and post-approval…

West Pharmaceutical Services (NYSE:WST) announced the opening of a new facility for contract services in Dublin, Ireland. IDA Ireland, the foreign direct investment arm for the Irish government, shared the announcement of the Damastown site’s opening. The 165,000-square-foot expansion enhances West’s contract services. It helps meet the growing demand for high-volume treatments, including for diabetes…

Thermo Fisher Scientific today announced a strategic collaboration with drug delivery system provider SHL Medical. The collaboration coincides with the expansion of sterile fill-finish and auto-injector final assembly capacity at its Ridgefield, New Jersey site. Together, Thermo Fisher says its investments establish a fully integrated U.S.-based offering across sterile manufacturing, device assembly and commercial packaging…

Wilmington PharmaTech announced a $50 million investment to expand its Delaware campus for active pharmaceutical ingredient (API) manufacturing. Newark, Delaware-based Wilmington PharmaTech said the expansion more than doubles its current API reactor capacity. It adds two new 10,000-liter reactor suites to increase commercial-scale manufacturing capabilities. This supports growing demand for high-quality, U.S.-based manufacturing as the…

Cambrex announced today that it achieved multiple milestones in its effort to expand its active pharmaceutical ingredient (API) manufacturing. East Rutherford, New Jersey-based Cambrex said it completed the initial engineering studies for a new, large-scale API manufacturing plant in Charles City, Iowa. It also added further investment to support its Milan, Italy, site. The latest…

BioDuro announced that it established a joint venture with Cenra API Solutions, also known as Chunghwa Chemical Synthesis & Biotech Co. The joint venture aims to combine the services of the CRDMO and a pharmaceutical chemical manufacturer. They hope to add significant commercial-scale active pharmaceutical ingredient (API) manufacturing capacity at Cenra’s campus in Taipei, Taiwan, to…

Bora Pharmaceuticals and GSK announced today that they entered into a $250 million agreement to renew a five-year manufacturing partnership. In 2020, Bora purchased a facility in Mississauga, Ontario, from GSK. Now, they say the renewed collaboration reinforces their long-standing relationship and expands their partnership. It also provides GSK access to multiple sites within the…

Healthcare CDMO manufacturer MGS has brought a 300,000 square foot drug delivery device manufacturing facility online in Richfield, Wisconsin. The move expands U.S. production capacity as demand for complex combination products strains available cleanroom capacity . FDA approved a record number of combination products in recent years, and the 505(b)(2) pathway has made device-drug combos…